Rosiglitazone attenuates cell apoptosis through antioxidative and anti-apoptotic pathways in the hippocampi of spontaneously hypertensive rats

Li,Yali; Yu,Guanghu; Liu,Lijuan; Long,Jun; Su,Shujie; Zhao,Ting; Liu,Wenjin; Shen,Shunji; Niu,Xiaolin

doi:10.3892/ijmm.2018.3991

Rosiglitazone attenuates cell apoptosis through antioxidative and anti-apoptotic pathways in the hippocampi of spontaneously hypertensive rats

Authors:
- Yali Li
- Guanghu Yu
- Lijuan Liu
- Jun Long
- Shujie Su
- Ting Zhao
- Wenjin Liu
- Shunji Shen
- Xiaolin Niu
View Affiliations

Affiliations: Department of Rehabilitation, Weihai Municipal Hospital, Weihai, Shandong 264200, P.R. China, Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shanxi 710004, P.R. China
Published online on: November 19, 2018 https://doi.org/10.3892/ijmm.2018.3991
Pages: 693-700

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oxidative stress serves an important role in hypertensive brain damage. Peroxisome proliferator‑activated receptor γ (PPAR‑γ) agonists possess antioxidative and anti‑apoptotic effects. The present study verified the possibility that rosiglitazone serves a neuroprotective role by alleviating oxidative stress and cell apoptosis in the hippocampi of spontaneously hypertensive rats (SHRs). SHRs and age‑matched Wistar‑Kyoto (WKY; both 56 weeks old) rats received gavage administration of vehicle or rosiglitazone (5 mg/kg/day) for eight weeks. Systolic blood pressure (SBP) was measured by the indirect tail‑cuff method. The expression ratio of activated astrocytes was analyzed by glial fibrillary acidic protein immunohistochemistry. PPAR‑γ, inducible nitric oxide synthase (iNOS), gp47phox, B‑cell lymphoma 2 (Bcl‑2), Bcl‑2‑associated X protein (Bax) and caspase‑3 expression were investigated by quantitative polymerase chain reaction and western blot analysis. The number of apoptotic cells in the hippocampus of four groups was detected using the terminal deoxynucleotidyl transferase‑mediated dUTP end‑labeling (TUNEL) method. Compared with the WKY group, the SHR group exhibited decreased Bcl‑2 and PPAR‑γ expression, increased SBP, increased ratio of activated astrocytes and TUNEL‑positive cells, increased expression of iNOS, gp47phox, caspase‑3 and Bax. Rosiglitazone administration increased Bcl‑2 and PPAR‑γ expression, decreased the ratio of activated astrocytes and TUNEL‑positive cells, decreased iNOS, gp47phox, caspase‑3 and Bax expression in the hippocampi of SHRs. However, rosiglitazone did not significantly decreased SBP in the SHR group. Therefore, rosiglitazone exerts neuroprotective effect through antioxidative and anti‑apoptotic pathways, which was independent of blood pressure control.

View Figures

View References

1	Selvetella G, Notte A, Maffei A, Calistri V, Scamardella V, Frati G, Trimarco B, Colonnese C and Lembo G: Left ventricular hypertrophy is associated with asymptomatic cerebral damage in hypertensive patients. Stroke. 34:1766–1770. 2003. View Article : Google Scholar : PubMed/NCBI
2	Turer AT and Hill JA: Pathogenesis of myocardial ischemia-reper-fusion injury and rationale for therapy. Am J Cardiol. 106:360–368. 2010. View Article : Google Scholar : PubMed/NCBI
3	Eltzschig HK and Eckle T: Ischemia and reperfusion-from mechanism to translation. Nat Med. 17:1391–1401. 2011. View Article : Google Scholar : PubMed/NCBI
4	Mohammadi MT and Dehghani GA: Acute hypertension induces brain injury and blood-brain barrier disruption through reduction of claudins mRNA expression in rat. Pathol Res Pract. 210:985–990. 2014. View Article : Google Scholar : PubMed/NCBI
5	Corona JC and Duchen MR: PPARgamma as a therapeutic target to rescue mitochondrial function in neurological disease. Free Radic Biol Med. 100:153–163. 2016. View Article : Google Scholar : PubMed/NCBI
6	Kvandova M, Majzunova M and Dovinova I: The role of PPARgamma in cardiovascular diseases. Physiol Res. 65:S343–S363. 2016.PubMed/NCBI
7	Chaudhry A, Carthan KA, Kang BY, Calvert J, Sutliff RL and Michael Hart C: PPARgamma attenuates hypoxia-induced hypertrophic transcriptional pathways in the heart. Pulm Circ. 7:98–107. 2017. View Article : Google Scholar : PubMed/NCBI
8	Lan LF, Zheng L, Yang X, Ji XT, Fan YH and Zeng JS: Peroxisome proliferator-activated receptor-gamma agonist pioglitazone ameliorates white matter lesion and cognitive impairment in hypertensive rats. CNS Neurosci Ther. 21:410–416. 2015. View Article : Google Scholar : PubMed/NCBI
9	Afzal S, Sattar MA, Johns EJ, Abdulla MH, Akhtar S, Hashmi F and Abdullah NA: Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-gamma), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats. J Physiol Biochem. 72:593–604. 2016. View Article : Google Scholar : PubMed/NCBI
10	Maccallini C, Mollica A and Amoroso R: The positive regulation of eNOS signaling by PPAR agonists in cardiovascular diseases. Am J Cardiovasc Drugs. 17:273–281. 2017. View Article : Google Scholar : PubMed/NCBI
11	Li Y, Liu J, Gao D, Wei J, Yuan H, Niu X and Zhang Q: Age-related changes in hypertensive brain damage in the hippocampi of spontaneously hypertensive rats. Mol Med Rep. 13:2552–2560. 2016. View Article : Google Scholar : PubMed/NCBI
12	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar
13	Imig JD, Walsh KA, Hye Khan MA, Nagasawa T, Cherian-Shaw M, Shaw SM and Hammock BD: Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor gamma agonist improve vascular function and decrease renal injury in hypertensive obese rats. Exp Biol Med (Maywood). 237:1402–1412. 2012. View Article : Google Scholar
14	Kadiiska MB, Bonini MG, Ruggiero C, Cleland E, Wicks S and Stadler K: Thiazolidinedione treatment decreases oxidative stress in spontaneously hypertensive heart failure rats through attenuation of inducible nitric oxide synthase-mediated lipid radical formation. Diabetes. 61:586–596. 2012. View Article : Google Scholar : PubMed/NCBI
15	Paravicini TM and Touyz RM: Redox signaling in hypertension. Cardiovasc Res. 71:247–258. 2006. View Article : Google Scholar : PubMed/NCBI
16	Patel M, Li QY, Chang LY, Crapo J and Liang LP: Activation of NADPH oxidase and extracellular superoxide production in seizure-induced hippocampal damage. J Neurochem. 92:123–131. 2005. View Article : Google Scholar
17	Jiang T, Gao L, Shi J, Lu J, Wang Y and Zhang Y: Angiotensin-(1-7) modulates renin-angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats. Pharmacol Res. 67:84–93. 2013. View Article : Google Scholar
18	Ramalingam M and Kim SJ: Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases. J Neural Transm (Vienna). 119:891–910. 2012. View Article : Google Scholar
19	Charriaut-Marlangue C and Ben-Ari Y: A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport. 7:61–64. 1995. View Article : Google Scholar : PubMed/NCBI
20	Napoleone P, Ferrante F, Ghirardi O, Ramacci MT and Amenta F: Age-dependent nerve cell loss in the brain of Sprague-Dawley rats: Effect of long term acetyl-L-carnitine treatment. Arch Gerontol Geriatr. 10:173–185. 1990. View Article : Google Scholar : PubMed/NCBI
21	Beach TG, Walker R and McGeer EG: Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia. 2:420–436. 1989. View Article : Google Scholar : PubMed/NCBI
22	Kvandová M, Majzúnová M and Dovinová I: The role of PPARgamma in cardiovascular diseases. Physiol Res. 65:S343–S363. 2016.PubMed/NCBI
23	Li WL, Liang X, Wang X, Zhang XD, Liu R, Zhang W, Chen HL, Qin XJ, Bai H and Hai CX: Protective effect of the peroxisome proliferator-activated receptor (PPAR)-gamma, ligand rosiglitazone on tertbutyl hydroperoxide-induced QZG cell injury. Exp Toxicol Pathol. 63:527–533. 2011. View Article : Google Scholar
24	Raji A, Seely EW, Bekins SA, Williams GH and Simonson DC: Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients. Diabetes Care. 26:172–178. 2003. View Article : Google Scholar
25	Dobrian AD, Schriver SD, Khraibi AA and Prewitt RL: Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension. 43:48–56. 2004. View Article : Google Scholar
26	de Dios ST, Bruemmer D, Dilley RJ, Ivey ME, Jennings GL, Law RE and Little PJ: Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation. Circulation. 107:2548–2550. 2003. View Article : Google Scholar : PubMed/NCBI
27	Wang TD, Chen WJ, Cheng WC, Lin JW, Chen MF and Lee YT: Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome. Am J Cardiol. 98:1057–1062. 2006. View Article : Google Scholar : PubMed/NCBI
28	Polikandriotis JA, Mazzella LJ, Rupnow HL and Hart CM: Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms. Arterioscler Thromb Vasc Biol. 25:1810–1816. 2005. View Article : Google Scholar
29	Chan SH, Wu KL, Kung PS and Chan JY: Oral intake of rosiglitazone promotes a central antihypertensive effect via upregulation of peroxisome proliferator-activated receptor-gamma and alleviation of oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertension. 55:1444–1453. 2010. View Article : Google Scholar : PubMed/NCBI
30	Walker AB, Chattington PD, Buckingham RE and Williams G: The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes. 48:1448–1453. 1999. View Article : Google Scholar : PubMed/NCBI